JCCC Research Seminar featuring Dr. Anusha Kalbasi
Part I: Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance / Part II: five-day neoadjuvant phase 2 study in soft tissue sarcoma
- Date: May 16, 2019 12:00 PM - 1:00 PM
- Location: 53-105 CHS
10833 Le Conte Ave.
Los Angeles, California 90095
Anusha Kalbasi, M.D.
Assistant Professor, Department of Radiation Oncology Division of Molecular and Cellular Oncology
Member, JCCC Tumor Immunology Program
Dr. Anusha Kalbasi’s research focuses on tumor immunology and cancer immunotherapy, with an emphasis on developing novel immunotherapeutic strategies in pre-clinical models and testing agents in early-phase clinical trials. His previous work, in melanoma, prostate cancer and pancreatic cancer, centered on genetic engineering of t-cells for adoptive cell therapy, modulating anti-tumor immunity through the CD40 pathway, developing immune-based cancer biomarkers and understanding myeloid-derived resistance to cytotoxic therapy.
Light lunch served
Sponsored by the UCLA Jonsson Comprehensive Cancer Center Tumor Immunology Program